Brief: C-Mer Eye Care Sees Adjusted EBITDA To Be Around HK$300 Mln For Year
05/02/2025 17:19
Feb 5 (Reuters) - C-Mer Medical Holdings Ltd 3309.HK :
* SEES ADJUSTED EBITDA TO BE AROUND HK$300 MILLION FOR YEAR
* SEES REVENUE TO BE AROUND HK$1,900 MILLION IN FY2024
* EXPECTED RESULT DUE TO WEAKER THAN EXPECTED PERFORMANCE OF
CERTAIN HOSPITALS AND CLINICS
* SEES PROFIT ATTRIBUTABLE TO BE WITHIN HK$50 MILLION TO
HK$60
MILLION FOR FY
Further company coverage: 3309.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on C-Mer Medical Holdings
See all newsC-Mer Eye Care's H1 revenue rises, net profit flat
Brief: C-Mer Eye Care Says HK (International) Eye Care To Subscribe For 6.72% Of Chigenovo
Brief: C-Mer Medical Holdings Expects FY2025 Profit Attributable Of HK$90 MLN-HK$110 MLN
Brief: C-Mer Eye Care Transfers 55% Of Apollo Lens Shares To Hong Kong Optical Lens
Brief: C-Mer Medical's Unit Enters Global Licensing Agreement